Renishaw announced that its pre-tax adjusted earnings increased in the first nine months of 2022, as it benefited from strong demand across all of its product lines and a strong order book.
The London-based healthcare technology company said its adjusted pre-tax profit for the nine months to March 31 was 4 124m ($ 152.9m), up from ,4 84.4m previously. a year.
Revenue rose 21% to 49 492.4m mainly due to processing technologies and despite a 1% drop in revenue from medical devices.
The company stressed that it expects revenues for the year 2022 at 655-675 million pounds, while the adjusted pre-tax profits are expected to reach 155-170 million pounds.
“The board remains confident in the long-term prospects, thanks to our strong financial position, the high quality of our people, innovative products, extensive sales and marketing presence and high value-added production,” said Renishaw. .
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
